IMMUNOMET THERAPEUTICS
ImmunoMet Therapeutics is a development-stage biopharmaceutical company focused on the development and commercialization of novel oncology products that are aimed to improve the quality of life of cancer patients. With more than 6 years of experience in the field of cancer metabolism and immunometabolism, ImmunoMet has developed a comprehensive pipeline of metabolic regulators preferentially targeting the cellular metabolism of drug-resistant cancer subpopulations and immuno-suppressors of anti-cancer effector T cells.
IMMUNOMET THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.immunomet.com
Total Employee:
1+
Status:
Active
Contact:
+119196161923
Email Addresses:
[email protected]
Total Funding:
17.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AmXpress
AmXpress is a medicine testing industries that specializes in chromatography products for chemical analysis.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
NHN Investment
NHN Investment investment in Venture Round - ImmunoMet Therapeutics
G.N. Tech Venture
G.N. Tech Venture investment in Venture Round - ImmunoMet Therapeutics
SL Investment
SL Investment investment in Venture Round - ImmunoMet Therapeutics
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Venture Round - ImmunoMet Therapeutics
SL Investment
SL Investment investment in Series B - ImmunoMet Therapeutics
InterVest
InterVest investment in Series B - ImmunoMet Therapeutics
NHN Investment
NHN Investment investment in Series B - ImmunoMet Therapeutics
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series B - ImmunoMet Therapeutics
G.N. Tech Venture
G.N. Tech Venture investment in Series B - ImmunoMet Therapeutics
Sungwuk Kim
Sungwuk Kim investment in Series B - ImmunoMet Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-26 | Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer |
Official Site Inspections
http://www.immunomet.com
- Host name: box2102.bluehost.com
- IP address: 74.220.219.13
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
